|
**Overview**: Allergy Mold Panel**Introduction**: The Allergy Mold Panel is a diagnostic tool designed to screen for mold allergies using serum samples. In India, mold sensitization is prevalent in humid and monsoon-prone regions (Aspergillus, Alternaria, Penicillium, Cladosporium common), contributing to allergic rhinitis and asthma with rates 10-30 percent in respiratory cohorts. Symptoms include nasal congestion, wheezing, cough, and eye irritation, worsening in damp homes or post-rain. High morbidity from underdiagnosis in low-SES urban/rural households with poor ventilation and mold growth. Per immunology practices (ICMR aligned), the test employs immunoassay for detailed parameter analysis over 1-2 days with high sensitivity/specificity, valuable for identifying mold triggers in persistent cases. This diagnostic falls under allergy screening and targets individuals with suspected mold allergies, addressing accurate detection to guide environmental control and therapy. With morbidity elevated due to underdiagnosis in humid climates, the test supports public health efforts by enabling precise identification, facilitating management, and reducing chronic symptoms. Its serum-based approach ensures reliable detection.**Other Names**: Mold Pnl.**FDA Status**: FDA approved, CLIA certified for immunology, compliant with 2025 standards.**Historical Milestone**: Expanded with specific IgE testing; in India, relevance with monsoon-related mold exposure.**Purpose**: The test screens for 5 parameters including Aspergillus IgE to guide mold allergy assessment, identify triggers, inform treatment strategies.**Test Parameters**: 1. Aspergillus IgE, 2. Alternaria IgE, 3. Penicillium IgE, 4. Cladosporium IgE, 5. Total IgE.**Pretest Condition**: No fasting required; patients should report worsening symptoms in damp or moldy environments.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on home mold exposure, symptom patterns, damp living conditions, or family atopy.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated mold allergies including chronic respiratory issues, benefits of early detection, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols, and store kits according to manufacturer specifications to ensure reliability.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis, or concurrent infections can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Abnormal results indicate possible mold triggers, necessitating further investigation like specialist consultation or additional testing. Normal results may require follow-up if symptoms persist.**Specialist Consultation**: Allergists or pulmonologists should be consulted for case management, environmental control planning, and coordination with health programs.**Additional Supporting Tests**: Home mold inspection or air sampling for confirmation.**Test Limitations**: The test may produce false negatives in low exposure or false positives in sensitization without clinical disease, requiring a comprehensive diagnostic approach that includes clinical correlation.**References**: Indian Journal of Allergy Asthma Immunology 2024, Mold Sensitization Studies India 2023. |
